PrEP-aring the General Gynecologist to Offer HIV Pre-exposure Prophylaxis

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


It is estimated that 450,000 American women are at increased risk of infection with human immunodeficiency virus (HIV), and yet only 7% have a prescription for pre-exposure prophylaxis (PrEP). PrEP is a safe and effective method of HIV infection prevention via a daily use of an oral combination antiretroviral pill or longer-acting intramuscular injections. Gynecologists are experts in women's sexual health, and provide over half of annual preventative health visits, but are not yet routinely providing PrEP to patients, citing lack of knowledge as a major barrier. The authors aim to provide the general gynecologist with the skills to expertly provide PrEP to their patients to reduce HIV infection.

Original languageEnglish (US)
Pages (from-to)733-738
Number of pages6
JournalClinical Obstetrics and Gynecology
Issue number4
Early online date2022
StatePublished - Dec 1 2022

Bibliographical note

Publisher Copyright:
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

PubMed: MeSH publication types

  • Journal Article


Dive into the research topics of 'PrEP-aring the General Gynecologist to Offer HIV Pre-exposure Prophylaxis'. Together they form a unique fingerprint.

Cite this